학술논문

Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets
Document Type
article
Source
Cell Reports. 21(9)
Subject
Biological Sciences
Genetics
Mental Health
Aging
Brain Disorders
Biotechnology
Autoimmune Disease
Neurosciences
Human Genome
2.1 Biological and endogenous factors
Aetiology
Underpinning research
1.1 Normal biological development and functioning
Mental health
Neurological
Cefotaxime
Cognition
Female
Genetic Loci
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Male
Nootropic Agents
Polymorphism
Single Nucleotide
Synapses
GWAS
calcium channel
cerebellum
gene expression
general cognitive ability
neurodevelopment
nootropics
potassium channel
synapse
Biochemistry and Cell Biology
Medical Physiology
Biological sciences
Language
Abstract
Here, we present a large (n = 107,207) genome-wide association study (GWAS) of general cognitive ability ("g"), further enhanced by combining results with a large-scale GWAS of educational attainment. We identified 70 independent genomic loci associated with general cognitive ability. Results showed significant enrichment for genes causing Mendelian disorders with an intellectual disability phenotype. Competitive pathway analysis implicated the biological processes of neurogenesis and synaptic regulation, as well as the gene targets of two pharmacologic agents: cinnarizine, a T-type calcium channel blocker, and LY97241, a potassium channel inhibitor. Transcriptome-wide and epigenome-wide analysis revealed that the implicated loci were enriched for genes expressed across all brain regions (most strongly in the cerebellum). Enrichment was exclusive to genes expressed in neurons but not oligodendrocytes or astrocytes. Finally, we report genetic correlations between cognitive ability and disparate phenotypes including psychiatric disorders, several autoimmune disorders, longevity, and maternal age at first birth.